1. Home
  2. CGEM vs FSBC Comparison

CGEM vs FSBC Comparison

Compare CGEM & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • FSBC
  • Stock Information
  • Founded
  • CGEM 2016
  • FSBC 2002
  • Country
  • CGEM United States
  • FSBC United States
  • Employees
  • CGEM N/A
  • FSBC N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • FSBC Banks
  • Sector
  • CGEM Health Care
  • FSBC Finance
  • Exchange
  • CGEM Nasdaq
  • FSBC Nasdaq
  • Market Cap
  • CGEM 506.1M
  • FSBC 606.0M
  • IPO Year
  • CGEM 2021
  • FSBC 2021
  • Fundamental
  • Price
  • CGEM $7.51
  • FSBC $27.74
  • Analyst Decision
  • CGEM Strong Buy
  • FSBC Buy
  • Analyst Count
  • CGEM 8
  • FSBC 4
  • Target Price
  • CGEM $32.86
  • FSBC $36.13
  • AVG Volume (30 Days)
  • CGEM 400.4K
  • FSBC 84.2K
  • Earning Date
  • CGEM 05-14-2025
  • FSBC 04-28-2025
  • Dividend Yield
  • CGEM N/A
  • FSBC 2.88%
  • EPS Growth
  • CGEM N/A
  • FSBC N/A
  • EPS
  • CGEM N/A
  • FSBC 2.26
  • Revenue
  • CGEM N/A
  • FSBC $119,214,000.00
  • Revenue This Year
  • CGEM N/A
  • FSBC $24.83
  • Revenue Next Year
  • CGEM $278.37
  • FSBC $13.57
  • P/E Ratio
  • CGEM N/A
  • FSBC $12.31
  • Revenue Growth
  • CGEM N/A
  • FSBC 4.22
  • 52 Week Low
  • CGEM $7.30
  • FSBC $21.10
  • 52 Week High
  • CGEM $30.19
  • FSBC $35.13
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 31.21
  • FSBC 34.60
  • Support Level
  • CGEM $8.01
  • FSBC $27.35
  • Resistance Level
  • CGEM $9.16
  • FSBC $28.99
  • Average True Range (ATR)
  • CGEM 0.46
  • FSBC 1.03
  • MACD
  • CGEM -0.04
  • FSBC 0.02
  • Stochastic Oscillator
  • CGEM 9.62
  • FSBC 18.04

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

Share on Social Networks: